Services aux conférences Mandl

Résumé: The Society's annual conference combines a forum on developments in the professional practice of pharmacy with a major international platform for new work in the pharmaceutical sciences.

The conference takes place every year in the autumn, at venues around the country. An exhibition runs in conjunction with the conference.

Résumé: IQPC’s Pharma IQ’s Biobanking conference will show professionals working in Labs, Biorepositories, Bioanalysis and R&D how to set up productive biological sample management efforts; including assessing the latest automation systems; how to accurately assess samples including DNA, Blood and Human tissues; understand and work with Regulations and Bioethical challenges; and effectively collect and manage patient information.

Résumé: This conference will encompass six sessions in two days. Each will focus on a different area of Drug Discovery from selecting compounds for the corporate collection, liquid handling and detection technologies, plus advances in assay development and screening. Two sessions will address the biochemistry of two important different target classes: Enzymes and G-protein coupled receptors. Biopharmaceuticals will form the sixth session. As with our highly successful meeting in 2007, attendees will hear world class speakers discussing the challenges facing the drug discovery scientist. The scientific sessions will be complemented by plenary keynote presentations from two of the field's foremost researchers, a poster session and a vendor exhibition with over 80 exhibitors.

Résumé: A brand new DIA Conference featuring an expert programme committee and speakers from the EMEA, CHMP Working Group, EFPIA, European Commission, EBE, EuropaBio, Eucomed and senior representatives from industry. The conference will involve all stakeholders including regulators, industry, academia and patient groups. The conference is organised over two days. The first day will address the progress with the implementation of the Innovative Medicines Initiative and the EMEA initiatives in relation to support innovation including the qualification of biomarkers and new methodologies. The second day will focus on the practical aspects to implement the Regulation on Advanced Therapy.

Résumé: This prestigious and focussed international meeting is aimed at pharmaceutical and analytical scientists who are involved in the design and execution of photostability and phototoxicity studies; project managers who need to know about the impact of photostability issues on drug development and pharmaceutical industry users who need to identify critical issues in the management of photostability studies.

Résumé: To update delegates on the progress of the Electronic Prescription Service (EPS) - part of the National Programme for IT and explore the practicalities involved in terms of community pharmacy services in England.

To discuss how pharmacists can rise to the challenges that these radical changes will bring and explore innovative ways to ensure business continuity.

To examine in workshop sessions the importance of information governance and consider the implications of role-based access to the Summary Care Records for community pharmacists.

To equip delegates with enhanced knowledge on e-care pathways and consider how the Map of Medicine and NHS Choices can support pharmacists in delivering healthcare to the community.

Résumé: Bench2Boardroom is now clearly established as the event for the UK's biotech and medtech communities. Once again, delegates benefited from an update on services, products and best practice as well as peer to peer networking and expert advice. The online facility available prior to the event was extremely popular this year, allowing individuals to capitalise on their Bench2Boardroom day by pre-planning their personal agendas and one to one meetings.

Bench2Boardroom 2008 will be held on 15 October 2008, at Chilford Hall.

Résumé: The Quality Control Laboratory, in both the R & D and Operations environment, is a key element of the supply chain and has a particularly significant impact on lead times, affecting speed of drug development and overall site manufacturing performance.

As the UK pharmaceutical industry faces ever-increasing competition from abroad, the enhancement of laboratory productivity to improve the product-process development cycle and manufacturing efficiency has become even more crucial for the long-term viability of UK-based sites.

This symposium will review advances in laboratory efficiency which, both individually and collectively, are designed to achieve these outcomes, through the adoption of process-based improvement tools, automation and integrated data handling within the laboratory.

Résumé: This course will be registered by the College of Pharmacy Practice as providing approx. 3 contact hours of post graduate education towards the College’s continuing education requirement and a Certificate will be delivered to those attending the seminar.

Résumé: This workshop will present drug release methodologies to evaluate the product performance for special dosage forms, such as, buccal, topical, ophthalmic, inhalation, stent and nanoparticle formulations. It will provide opportunities for the participants to interact with the faculty in panel discussions.

Résumé: Bio-International 2008 aims to develop a common approach for tackling complex issues such as Bioequivalence/interchangeability of Cytotoxic Drug Products, Topical Drug Products and Respiratory Drug Products. The use of Comparator Drug Products for establishing Bioequivalence is a burning issue in the assessment of Multisource Drug Products quality and will be discussed along with application of Biopharmaceutics Classification System in assessing Bioequivalence of oral products. There will also be a special session highlighting BE issues in many countries and how these issues can be resolved with the experience gained with similar issues in other parts of the world. The format of Bio-International 2008 will include plenary presentations by leading international experts, panel discussions and questions from delegates for response by speakers.

The conference is designed to follow the pre-satellite FIP/SIG workshop Special dosage forms – What’s new with in vitro drug release? (20-21 October, RPSGB, London). Delegates at this conference are invited to sign-up for both events for a discounted combined fee.

For further details on the workshop, please see www.rpsgb.org/worldofpharmacy/events or email science@rpsgb.org.

Résumé: This 2 day course considers the regulatory aspects of the fine chemical and pharmaceutical industries, with emphasis on their practical application in chemical development. Its purpose is to encourage chemists based in lab or pilot plant to develop a balanced and practical perspective on GMP.

Résumé: While the UK pharmacy degree continues to be internationally recognised for its scope and quality, it is nevertheless essential to ensure that there is a suitable level of connection between the educational outputs of the degree and the needs of the profession. This meeting is intended to bring together academics, policy makers, employers and recent graduates in order to exchange views on how we should address current needs and future changes in the profession at the undergraduate level.

Résumé: Overview This 2 day course is aimed at Quality Assurance auditors and production management for Level 2 internal audits and supplier auditing. To be a business benefit rather than a drain on resources, your auditing programmes must be integral to continuous improvement. The key to effective internal auditing and auditing of suppliers is the training of both auditors and auditees in the purpose and relevant techniques of the audit and how these techniques can be channeled to achieve business and compliance improvements. Participants will learn about the key techniques and thought processes which may be used by auditors to maximize the benefits of each type of audit.

Résumé: Synopsis This one day seminar is aimed at QA staff in drug products manufacturers and especially their QPs who have specific responsibilities under directive 2004/27/EC. QPs are required to declare that the active materials used in each of their products have been manufactured to GMP as interpreted by the EU. Participants will learn about the legislators' perspectives and the key differences between APIs and products, which lead to different audit techniques and thought processes when auditing API manufacturers. The seminar includes: the background to current GMPs for APIs FDA and EU interpretation of GMPs for APIs specific opportunities from the guidelines that API manufacturers may exploit

Résumé: An intensive course on the formulation, production and properties of pharmaceutical tablets. This course will examine the basic concepts of equipment selection, granulation and end-point determination, formulation optimisation and prediction, in-process monitoring (PAT), film coating and official and non-official dissolution tests. The course is designed to be applicable to the day to day problems of tabletting, linked to a sound theoretical knowledge of the principles involved.

Résumé: Chirality in Drug Compounds is launching this year after the great success of the focus day in March of this year. With new informative case studies, groundbreaking technology and strategic updates, this is your chance to get completely up to date in the area of chirality in drug compounds, for future effective drug development. Scientific Benefits of Attending: - Ensure efficacy of pharmaceutical compounds through effective molecular recognition and separation techniques - Increase percentage yield by creating enantiopure solid state forms - Explore biocatalysis and a-symmetric hydrogenation in synthesis to provide new chiral structures Business Benefits of Attending: - Find the optimum strategy to employ when dealing with chiral separations to minimise research costs - To reduce time to market - Benchmark production processes and separation techniques to employ the most cost-effective method in your research projects With nine networking opportunities, Chirality in Drug Compounds will give you the chance to use your time out of office to learn from the experts in the field for improved strategies, analytical techniques and cost-effective strategic changes.

Résumé: This symposium will explore the use of dissolution testing in the development and control of a range of dosage forms. Invited speakers will describe the pharmacopoeial methods that are available, discuss equipment requirements with respect to qualification and calibration, and provide practical examples of how these methods are used during development and routine quality control.

The symposium will discuss the use, regulatory acceptance and further development of the Biopharmaceutics Classification System and describe how it may be used to justify “biowaivers”. Setting specifications for modified release products will be discussed and supported by examples of in-vitro – in vivo correlations (IVIVC) and how this can support post-approval changes.

Résumé: All cells contain a diverse range of repair pathways that have evolved to optimize their survival following damage to their DNA. These pathways involve the actions of a large number of DNA repair proteins to remove the damage and maintain genome stability. Clearly, when these processes do not function correctly, a likely result will be instability of the genome. A large body of experimental data has demonstrated that such genetic instability can cause a wide variety of human diseases. This meeting will highlight recent major advances in understanding biochemical details about how DNA repair intersects with cellular pathways that lead to cancer or ageing. The meeting is particularly timely since it is now apparent that these biochemical processes offer significant potential for novel therapies to treat diseases such as cancer.

Résumé: An up-to-date and well-established residential course

Résumé: This ever popular training course for chemists and engineers in industry aims to discuss the most efficient methods for developing cheap, robust processes. It covers the principles of scale-up and development and provides examples and case studies from industry. Not to be missed if you are just starting work in development and useful as a refresher for those more established in the field.